For Localized NSCLC, Vaccine-Based Immunotherapy Does Not Affect Survival – Journal of Clinical Pathways
For Localized NSCLC, Vaccine-Based Immunotherapy Does Not Affect SurvivalJournal of Clinical PathwaysVaccine-based immunotherapy after surgery or radiotherapy did not increase survival in patients with localized non-small-cell lung cancer (NSCLC), acco… Continue reading
